A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
2018
European Heart Journal
Preserved Fulltext
The publication of the recent COMPASS study 1-3 raises key clinical questions: * Corresponding author. Tel: 0131 242 6378, Fax þ44 131 242 6379, Email: k.a.a.fox@ed.
doi:10.1093/eurheartj/ehy347
pmid:29945212
fatcat:ik2vkrypajbi3l5pbrrxnx66wm